Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.

Schütt, P; Brandhorst, D; Stellberg, W; Poser, M; Ebeling, P; Müller, S; Buttkereit, U; Opalka, B; Lindemann, M; Grosse-Wilde, H; Seeber, S; Moritz, T; Nowrousian, MR

Journal article

Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.

Abstract:: The present study evaluated cellular and humoral immune parameters in myeloma patients, focusing on the effect of treatment and the risk of opportunistic infections. Peripheral blood lymphocyte subsets and serum levels of nonmyeloma immunoglobulins (Ig) were analysed in 480 blood samples from 77 myeloma patients. Untreated myeloma patients exhibited significantly reduced CD4+/45RO+, CD19+, CD3+/HLA-DR+, and natural killer (NK) cells, as well as nonmyeloma IgA, IgG and IgM. Conventional-dose chemotherapy resulted in significantly reduced CD4+ and even further decline of CD4+/CD45RO+ and CD19+ cells, most notably in relapsed patients. Additional thalidomide treatment had no significant effects on these parameters. Following high-dose chemotherapy (HD-CTX), prolonged immunosuppression was observed. Although CD8+, NK, CD19+ and CD+/CD45RO+ cells recovered to normal values within 60, 90, 360 and 720 days, respectively, CD4+ counts remained reduced even thereafter. Nine opportunistic infections were observed, including five cytomegalovirus (CMV) diseases, one Pneumocystis carinii pneumonia (PCP) and three varicella zoster virus infections with CMV diseases and PCP occurring exclusively after HD-CTX. Opportunistic infections were correlated with severely reduced CD4+, as well as CD4+/CD45RO+ and CD19+ counts. Thus, myeloma patients display cellular and humoral immunodeficiencies, which increase following conventional as well as HD-CTX, and constitute an important predisposing factor for opportunistic infections.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Schütt, P., Brandhorst, D., Stellberg, W., Poser, M., Ebeling, P., Müller, S., Buttkereit, U., Opalka, B., Lindemann, M., Grosse-Wilde, H., Seeber, S., Moritz, T., & Nowrousian, M. R. (2006). Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leukemia and Lymphoma, 47(8), 1570–1582.

MLA Style

Schütt, P., et al. “Immune Parameters in Multiple Myeloma Patients: Influence of Treatment and Correlation with Opportunistic Infections.” Leukemia and Lymphoma, vol. 47, no. 8, 2006, pp. 1570–82.

Chicago Style

Schütt, P, D Brandhorst, W Stellberg, M Poser, P Ebeling, S Müller, U Buttkereit, et al. 2006. “Immune Parameters in Multiple Myeloma Patients: Influence of Treatment and Correlation with Opportunistic Infections.” Leukemia and Lymphoma 47 (8): 1570–82.
Share
Print